FDA Announces Class-Wide Label Changes To Combat Opioid Misuse

By Jessica Karins / December 15, 2023 at 6:52 PM

FDA is making class-wide changes to required labeling for opioid drugs and asking health care professionals to be more selective about prescribing opioid analgesic products, the agency announced Friday (Dec. 15).

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

FDA Announces Class-Wide Label Changes To Combat Opioid Misuse

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.